Cervicitis in pregnancy: a complex approach to diagnosis and treatment

Cover Page

Cite item

Full Text

Abstract

Cervicitis is an inflammatory process localized in columnar or stratified squamous non-keratinized epithelium of cervix uteri which can be infectious or non-infectious, acute or chronic. Acute cervicitis is associated with specific sexually transmittable causative pathogens as well as with bacterial vaginosis. Cervicitis clinical manifestations are non-specific and are characterized by plentiful puslike leucorrhea and contact bleeding. Elastography is an additional method for cervicitis diagnostics and treatment effectiveness evaluation. Clindamycin is the first-line drug for non-specific cervicitis treatment.

About the authors

Yu. E Dobrokhotova

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: katyanikitina@mail.ru
д-р мед. наук, проф., зав. каф. акушерства и гинекологии лечебного фак-та 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

E. I Borovkova

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

д-р мед. наук, проф. каф. акушерства и гинекологии лечебного фак-та 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

S. A Zalesskaya

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

ассистент, каф. акушерства и гинекологии лечебного фак-та 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

References

  1. Johnson L.F, Lewis D.A. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35: 946.
  2. Samantaray S, Parida G, Rout N et al. Cytologic detection of tuberculous cervicitis: a report of 7 cases. Acta Cytol 2009; 53: 594.
  3. Rodrigues M.M, Fernandes P.Á, Haddad J.P et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol 2011; 31: 237.
  4. Gaydos C, Maldeis N.E, Hardick A et al. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009; 36: 598.
  5. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012; 206: 476.e1.
  6. Workowski K.A, Bolan G.A; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 1.
  7. Lis R, Rowhani-Rahbar A, Manhart L.E. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015; 61: 418.
  8. Paraskevaides E.C, Wilson M.C. Fatal disseminated intravascular coagulation secondary to streptococcal cervicitis. Eur J Obstet Gynecol Reprod Biol 1988; 29: 39.
  9. Manhart L.E, Critchlow C.W, Holmes K.K et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187: 650.
  10. Marrazzo J.M, Wiesenfeld H.C, Murray P.J et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006; 193: 617.
  11. Nugent R.P, Hillier S.L. Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. The Investigators of the Johns Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Sex Transm Dis 1992; 19: 198.
  12. Paavonen J, Critchlow C.W, DeRouen T et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986; 154: 556.
  13. Marrazzo J.M, Handsfield H.H, Whittington W.L. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 2002; 100: 579.
  14. Koelle D.M, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116: 433.
  15. Huppert J.S, Mortensen J.E, Reed J.L et al. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35: 250.
  16. Short V.L, Totten P.A, Ness R.B et al. Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009; 48: 41.
  17. Marrazzo J.M, Martin D.H. Management of women with cervicitis. Clin Infect Dis 2007; 44 (Suppl. 3): S102.
  18. Kirkcaldy R.D, Kidd S, Weinstock H.S et al. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012. Sex Transm Infect 2013; 89 (Suppl. 4): iv5.
  19. Whittington W.L, Kent C, Kissinger P et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28: 117.
  20. Chandeying V, Sutthijumroon S, Tungphaisal S. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms. J Med Assoc Thai 1989; 72: 331.
  21. Schwebke J.R, Weiss H.L. Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002; 29: 59.
  22. Nyirjesy P. Nongonococcal and Nonchlamydial Cervicitis. Curr Infect Dis Rep 2001; 3: 540.
  23. Dunlop E.M, Garner A, Darougar S et al. Colposcopy, biopsy, and cytology results in women with chlamydial cervicitis. Genitourin Med 1989; 65: 22.
  24. Mena L.A, Mroczkowski T.F, Nsuami M, Martin D.H. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48: 1649.
  25. Schwebke J.R, Rompalo A, Taylor S et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis 2011; 52: 163.
  26. Jensen J.S, Cusini M, Gomberg M Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 2016; 30: 1650.
  27. Jensen J.S, Bradshaw C.S, Tabrizi S.N et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47: 1546.
  28. Bradshaw C.S, Chen M.Y, Fairley C.K. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3: e3618.
  29. Bissessor M, Tabrizi S.N, Twin J et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015; 60: 1228.
  30. Manhart L.E, Jensen J.S, Bradshaw C.S et al. Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections. Clin Infect Dis 2015; 61 (Suppl. 8): S802.
  31. Braam J.F, van Dommelen L, Henquet C.J et al. Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 2017. [Epub ahead of print] PMID: 28361246. https://doi.org/10.1007/s10096-017-2969-9
  32. Li Y, Le W.J, Li S et al. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS 2017: 956462416688562.
  33. Mattson S.K, Polk J.P, Nyirjesy P. Chronic Cervicitis: Presenting Features and Response to Therapy. J Low Genit Tract Dis 2016; 20: e30.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies